With the reform of the national health care system, the country before a lot of very expensive drugs become cheaper, but people surgery is also the focus of medical consumption, the state in order to deepen the reform of the field of high-value medical consumables centralized purchasing, which cardiac stents from 13,000 all of a sudden dropped to 700 yuan, triggering a lot of netizens to talk about. I think the price of cardiac stents is conducive to reducing the burden on patients, so that patients can spend less money to see a doctor, cardiac stent price drop will reduce overmedication, doctors will no longer be for the sake of the interests of the patients recommended to do cardiac stents, cardiac stent price is too low, may reduce the enthusiasm of medical equipment manufacturers.
I. A drop in the price of cardiac stents can reduce the burden on patients, so that patients can spend less money to see a doctor.People now see the doctor expensive, because of the high price of medical devices and drugs, heart stent prices from more than 10,000 reduced to a few hundred dollars, do the operation of the people all of a sudden the cost of reducing a lot of patients can reduce the burden, do the operation spend less money. The fall in the price of cardiac stents will benefit these patients, and future patients will also reduce this part of the cost expenditure, reducing the financial pressure.
II. The falling price of cardiac stents will reduce overmedication, and doctors will no longer recommend that patients get cardiac stents for profit.Cardiac stent use is more, and doctors recommend surgery can not be separated, now many hospital departments are independent accounting, in order to generate more income, many patients are overmedication. After the price of cardiac stents has fallen, doctors will no longer recommend patients for cardiac stent surgery because of the benefits, so overmedication will be reduced and many people will be able to recover slowly without surgery.
Third, the low price of cardiac stents may reduce the motivation of cardiac stent manufacturers.When the price of cardiac stents falls, the manufacturers who produce cardiac stents will have no profit, and if there is no profit in business activities, they will be less motivated to produce, and this is likely to reduce the supply of cardiac stents. Therefore to carry out healthcare reform, you can't just lower the price. Subsequent production should be prepared in advance.
What do you think about the matter of lowering the price of cardiac stents, welcome to leave a comment to discuss.